Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Larsen

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
Kidney International|June 18, 2016
The Authors ReplyChristopher P Larsen, Patrick D Walker
Kidney International|February 1, 2013
Redefining C3 glomerulopathy: 'C3 only' is a bridge too farChristopher P Larsen, Patrick D Walker
Journal of the American Society of Nephrology : JASN|January 10, 2015
Apolipoprotein L1-associated nephropathy and the future of renal diagnosticsChristopher P Larsen, Barry I Freedman
Kidney International|January 21, 2023
False-positive anti-PLA2R ELISA testing in patients with diabetes mellitusTiffany N Caza, Christopher P Larsen
Rheumatic Diseases Clinics of North America|October 3, 2018
Renal Manifestations of Inflammatory Bowel DiseaseJosephine M Ambruzs, Christopher P Larsen
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 16, 2017
Tissue staining for THSD7A in glomeruli correlates with serum antibodies in primary membranous nephropathy: a clinicopathological studyShree G Sharma, Christopher P Larsen
Kidney International Reports|December 23, 2017
Membranous Glomerulopathy With Light Chain-Restricted Deposits: A Clinicopathological Analysis of 28 CasesAlejandro Best Rocha, Christopher P Larsen
Kidney360|February 23, 2023
Serologic Studies in Membranous Nephropathy: Novel Strategies and Strengthened AssociationsTiffany N Caza, Christopher P Larsen
Kidney International|January 23, 2022
Lipoic acid in neural epidermal growth factor-like 1-associated membranous nephropathy: more than a coincidence?Tiffany N Caza, Christopher P Larsen
Transplantation|March 22, 2013
Phospholipase A2 receptor (PLA2R) staining is useful in the determination of de novo versus recurrent membranous glomerulopathyChristopher P Larsen, Patrick D Walker
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
Kidney International|June 18, 2016
The Authors ReplyChristopher P Larsen, Patrick D Walker
Kidney International|February 1, 2013
Redefining C3 glomerulopathy: 'C3 only' is a bridge too farChristopher P Larsen, Patrick D Walker
Journal of the American Society of Nephrology : JASN|January 10, 2015
Apolipoprotein L1-associated nephropathy and the future of renal diagnosticsChristopher P Larsen, Barry I Freedman
Kidney International|January 21, 2023
False-positive anti-PLA2R ELISA testing in patients with diabetes mellitusTiffany N Caza, Christopher P Larsen
Rheumatic Diseases Clinics of North America|October 3, 2018
Renal Manifestations of Inflammatory Bowel DiseaseJosephine M Ambruzs, Christopher P Larsen
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 16, 2017
Tissue staining for THSD7A in glomeruli correlates with serum antibodies in primary membranous nephropathy: a clinicopathological studyShree G Sharma, Christopher P Larsen
Kidney International Reports|December 23, 2017
Membranous Glomerulopathy With Light Chain-Restricted Deposits: A Clinicopathological Analysis of 28 CasesAlejandro Best Rocha, Christopher P Larsen
Kidney360|February 23, 2023
Serologic Studies in Membranous Nephropathy: Novel Strategies and Strengthened AssociationsTiffany N Caza, Christopher P Larsen
Kidney International|January 23, 2022
Lipoic acid in neural epidermal growth factor-like 1-associated membranous nephropathy: more than a coincidence?Tiffany N Caza, Christopher P Larsen
Transplantation|March 22, 2013
Phospholipase A2 receptor (PLA2R) staining is useful in the determination of de novo versus recurrent membranous glomerulopathyChristopher P Larsen, Patrick D Walker
Pageof 11